Communiqués Cogstate Limited

Actions

CGS

AU000000CGS8

Recherche biotechnologique et médicale

Marché Fermé - Australian S.E. 08:10:10 09/09/2026			Varia. 5j.	Varia. 1 janv.
3,100 ^AUD	+1,64 %		+1,97 %	+37,17 %

18/08	Transcript : Cogstate Limited, 2026 Earnings Call, Aug 18, 2026
18/08	Cogstate Limited publie ses résultats pour l'exercice clos le 30 juin 2026	CI

Communiqués

20/02/25	Cogstate : Half Year Report – H1 FY2025	PU
30/10/24	Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment and Clinician Solutions Powered by AI and Advanced Analytics	AQ
14/10/24	Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer	GL
02/09/24	Cogstate : Annual Report – FY2024	PU
28/07/22	Cogstate : Business Update and June 2022 Quarter Cashflow	PU
20/06/22	Cogstate : Joins New Collaborative of Global Healthcare Leaders to Define Core Digital Measures for Alzheimer’s Disease	PU
14/06/22	Cogstate Announces Formation of Scientific Advisory Board	GL
14/06/22	Cogstate : Announces Formation of Scientific Advisory Board	PU
21/04/22	Cogstate : Investor Update	PU
21/04/22	Cogstate : Business Update and March 2022 Quarter Cashflow	PU
23/02/22	Cogstate : Half Year Report – H1 FY2022	PU
23/02/22	Cogstate : 1H22 Financial Results & Business Update	PU
23/02/22	Cogstate : Investor Briefing	PU
23/02/22	Cogstate : App 4D and Financial Statements Half-year Ended 31 Dec 2021	PU
23/02/22	Cogstate : Appendix 4D and Financial Statements for Half-year Ended 31 December 2021	PU
20/01/22	Cogstate : Investor Update	PU
20/01/22	Cogstate : Business Update and December 2021 Quarter Cashflow	PU
13/01/22	Cogstate : Eisai to Launch Digital Tool “Cogmate™ in Taiwan And Hong Kong	PU
03/12/21	Cogstate : Notification regarding unquoted securities - CGS	PU
30/11/21	Cogstate : Technology to be Installed on Japanese Smartphone Targeting Senior Population	PU
29/11/21	Cogstate : Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod	PU
26/10/20	Cogstate : Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies	AQ
23/03/20	Cogstate : EISAI TO LAUNCH DIGITAL TOOL 'NOUKNOW' IN JAPAN FOR REGULAR SELF-ASSESSMENT OF BRAIN PERFORMANCE	AQ
29/10/18	CogState : Change of Director’s Interest Notice	PU
24/10/18	CogState : Annual General Meeting Presentation	PU